H. Asakawa et al., ESTABLISHMENT OF ANAPLASTIC THYROID-CARCINOMA CELL-LINES USEFUL FOR ANALYSIS OF CHEMOSENSITIVITY AND CARCINOGENESIS, The Journal of clinical endocrinology and metabolism, 81(10), 1996, pp. 3547-3552
Anaplastic thyroid carcinoma (ATC) is usually associated with a poor p
rognosis, with most patients dying within a few months. The mechanism
of its carcinogenesis is unclear, and its rapid growth and spread ofte
n prevent effective surgical therapy. Thus, chemotherapy is necessary.
However, ATC is often resistant to anticancer drugs. Therefore, predi
ction of chemosensitivity is important in selecting appropriate treatm
ent. In this study, after the establishment of three cell lines (K119,
KOA2, and IAA) from patients with ATC, we analyzed them for abnormali
ties in certain oncogenes (myc, ras, ret, and c-erbB2) and the p53 tum
or suppressor gene. Only one of three cell lines (KOA2) had a N-ras mu
tation [codon 61 CAA(Gln)-->CGA(Arg)] and a p53 gene mutation [exon 6
codon 192 Caa(Gln)-->TAG(stop)]. We also investigated their in vitro d
rug sensitivity and compared it with clinical chemosensitivity, retros
pectively. In vitro drug sensitivity was determined using an adhesive
tumor cell culture system. Only the K119 cells were sensitive to adria
mycin and cisplatin in. vitro. The other two were resistant to them in
vitro. These results paralleled the clinical responses. We also evalu
ated the in vitro drug sensitivity of a poorly differentiated thyroid
carcinoma cell line (SMP) and papillary thyroid carcinoma cell lines (
NPA). None of the five cell lines expressed the multidrug resistance g
ene (mdr-1). In conclusion, we established ATC cell lines that are sui
table models for characterizing the nature of multidrug resistance and
carcinogenesis.